World Library  
Flag as Inappropriate
Email this Article

Glycogen storage disease type IV

Article Id: WHEBN0002975098
Reproduction Date:

Title: Glycogen storage disease type IV  
Author: World Heritage Encyclopedia
Language: English
Subject: Norwegian Forest cat, Glycogen storage disease, ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases, Renal glycosuria, Pyruvate carboxylase deficiency
Publisher: World Heritage Encyclopedia

Glycogen storage disease type IV

Glycogen storage disease type IV
Classification and external resources
ICD-10 E74.0
ICD-9-CM 271.0
OMIM 232500 263570 607839
DiseasesDB 5303
eMedicine med/910 ped/97
MeSH D006011
  • Glycogen storage disease type IV
  • Adult polyglucosan body disease

Glycogen storage disease type IV is a rare hereditary metabolic disorder. It is the result of a mutation in GBE1 gene, which causes a defect in the glycogen branching enzyme. Therefore, glycogen is not made properly and abnormal glycogen molecules accumulate in cells; most severely in cardiac and muscle cells. The severity of this disease varies on the amount of enzyme produced. Glycogen Storage Disease Type IV is autosomal recessive, which means each parent has a mutant copy of the gene but show no symptoms of the disease. It affects 1 in 800,000 individuals worldwide, with 3% of all Glycogen Storage Diseases being type IV.[1]


  • Synonyms 1
  • Eponym 2
  • Human pathology 3
  • Variant types 4
    • Fatal perinatal neuromuscular type 4.1
    • Congenital muscular type 4.2
    • Progressive hepatic type 4.3
    • Non-progressive hepatic type 4.4
    • Childhood neuromuscular type 4.5
  • In animals 5
  • References 6
  • External links 7


It is also known as:

  • Glycogenosis type IV
  • Glycogen branching enzyme deficiency
  • Polyglucosan body disease
  • Amylopectinosis


The eponym "Andersen's disease" is sometimes used, for Dorothy Hansine Andersen.[2][3]

Human pathology

It is a result of the absence of the glycogen branching enzyme amylo-1,4-1,6 transglucosidase, which is critical in the production of glycogen. This leads to very long unbranched glucose chains being stored in glycogen. The long unbranched molecules have a low solubility which leads to glycogen precipitation in the liver. These deposits subsequently build up in the body tissue, especially the heart and liver. The inability to breakdown glycogen in muscle cells causes muscle weakness. The probable end result is cirrhosis and death within 5 years. In adults, the activity of the enzyme is higher and symptoms do not appear until later in life.

Variant types

Fatal perinatal neuromuscular type

  • Excess fluid builds up around fetus and in the fetus’ body
  • Fetus have condition called akinesia deformation sequence
  • Causes decrease in fetal movement and stiffness of joints after birth
  • Infants have low muscle tone and muscle wasting
  • Do not survive past newborn stage due to weakened heart and lungs

Congenital muscular type

  • Develops in early infancy
  • Babies have dilated cardiomyopathy, preventing heart from pumping efficiently
  • Only survive a few months

Progressive hepatic type

  • Infants have difficulty gaining weight
  • Develop enlarged liver and cirrhosis, that is irreversible
  • High BP in hepatic portal vein and buildup of fluid in abdominal cavity
  • Die of liver failure in early childhood

Non-progressive hepatic type

  • Same as progressive, but liver disease is not as severe
  • Do not usually develop cirrhosis
  • Usually show muscle weakness and hypotonia
  • Survive into adulthood
  • Life expectancy varies on severity of symptoms

Childhood neuromuscular type

  • Develops in late childhood
  • Has myopathy and dilated cardiomyopathy
  • Varies greatly
  • Some have mild muscle weakness
  • Some have severe cardiomyopathy and die in early adulthood

In animals

In horses: it has been reported in American Quarter Horses and related breeds.

In cats: the disease has been reported in the Norwegian Forest Cat, where it causes skeletal muscle, heart, and CNS degeneration in animals greater than 5 months old. It has not been associated with cirrhosis or liver failure.[4]


  1. ^ "Glycogen Storage Disease Type IV." Genetics Home Reference. U.S. National Library of Medicine, 10 Sept. 2015. Web. 27 Sept. 2015.
  2. ^ Andersen's disease (Dorothy Hansine Andersen) at Who Named It?
  3. ^ Andersen DH (1956). "Familial cirrhosis of the liver with storage of abnormal glycogen". Lab. Invest. 5 (1): 11–20.  
  4. ^ Fyfe, JC, Giger, U, VanWinkle, TJ, Haskins, ME, Steinberg, SA, et al. 1992Glycogen storage disease type IV: Inherited deficiency of branching enzyme activity in catsPediatr Res32719725

External links

  • Glycogen storage disease type IV at GPnotebook
  • Asociación Española de Enfermos de Glucogenosis

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.